Zobrazeno 1 - 10
of 254
pro vyhledávání: '"F. Geoghegan"'
Autor:
Ryan M. Esquejo, Christopher T. Salatto, Jake Delmore, Bina Albuquerque, Allan Reyes, Yuji Shi, Rob Moccia, Emily Cokorinos, Matthew Peloquin, Mara Monetti, Jason Barricklow, Eliza Bollinger, Brennan K. Smith, Emily A. Day, Chuong Nguyen, Kieran F. Geoghegan, John M. Kreeger, Alan Opsahl, Jessica Ward, Amit S. Kalgutkar, David Tess, Lynne Butler, Norimitsu Shirai, Timothy F. Osborne, Gregory R. Steinberg, Morris J. Birnbaum, Kimberly O. Cameron, Russell A. Miller
Publikováno v:
EBioMedicine, Vol 31, Iss , Pp 122-132 (2018)
Dysregulation of hepatic lipid and cholesterol metabolism is a significant contributor to cardiometabolic health, resulting in excessive liver lipid accumulation and ultimately non-alcoholic steatohepatitis (NASH). Therapeutic activators of the AMP-A
Externí odkaz:
https://doaj.org/article/3a6b1a8ecd964eee8550aafb2b27ef05
Autor:
Andrea M. Zuhl, Charles E. Nolan, Michael A. Brodney, Sherry Niessen, Kevin Atchison, Christopher Houle, David A. Karanian, Claude Ambroise, Jeffrey W. Brulet, Elizabeth M. Beck, Shawn D. Doran, Brian T. O’Neill, Christopher W. am Ende, Cheng Chang, Kieran F. Geoghegan, Graham M. West, Joshua C. Judkins, Xinjun Hou, David R. Riddell, Douglas S. Johnson
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-14 (2016)
Several β-secretase (BACE) inhibitors exhibit unexplained ocular toxicity in preclinical studies. Here the authors generate a clickable photoaffinity probe to interrogate off-targets in cells and animals, and identify inhibition of cathepsin D as a
Externí odkaz:
https://doaj.org/article/5dfe4a29e6af43a49ee6c24207abc513
Autor:
Nathanael G Lintner, Kim F McClure, Donna Petersen, Allyn T Londregan, David W Piotrowski, Liuqing Wei, Jun Xiao, Michael Bolt, Paula M Loria, Bruce Maguire, Kieran F Geoghegan, Austin Huang, Tim Rolph, Spiros Liras, Jennifer A Doudna, Robert G Dullea, Jamie H D Cate
Publikováno v:
PLoS Biology, Vol 16, Iss 4, p e1002628 (2018)
[This corrects the article DOI: 10.1371/journal.pbio.2001882.].
Externí odkaz:
https://doaj.org/article/3cb85e619abd466a91199f6643f6fcd9
Autor:
Nathanael G Lintner, Kim F McClure, Donna Petersen, Allyn T Londregan, David W Piotrowski, Liuqing Wei, Jun Xiao, Michael Bolt, Paula M Loria, Bruce Maguire, Kieran F Geoghegan, Austin Huang, Tim Rolph, Spiros Liras, Jennifer A Doudna, Robert G Dullea, Jamie H D Cate
Publikováno v:
PLoS Biology, Vol 15, Iss 3, p e2001882 (2017)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a key role in regulating the levels of plasma low-density lipoprotein cholesterol (LDL-C). Here, we demonstrate that the compound PF-06446846 inhibits translation of PCSK9 by inducing the ri
Externí odkaz:
https://doaj.org/article/c8c20b848f9a4b7e848edcb19074a5c8
Autor:
Jessica Ward, Jason Barricklow, Chuong Nguyen, Eliza Bollinger, Christopher T. Salatto, Bina Albuquerque, Mara Monetti, Norimitsu Shirai, Emily A. Day, Emily Cokorinos, Kieran F. Geoghegan, Gregory R. Steinberg, Rob Moccia, Matthew Peloquin, Ryan M. Esquejo, Morris J. Birnbaum, Russell A. Miller, Alan C. Opsahl, Brennan K. Smith, Jake Delmore, Kimberly O. Cameron, Timothy F. Osborne, Allan R. Reyes, John M. Kreeger, Lynne Butler, David A. Tess, Amit S. Kalgutkar, Yuji Shi
Publikováno v:
EBioMedicine, Vol 31, Iss, Pp 122-132 (2018)
EBioMedicine
EBioMedicine
Dysregulation of hepatic lipid and cholesterol metabolism is a significant contributor to cardiometabolic health, resulting in excessive liver lipid accumulation and ultimately non-alcoholic steatohepatitis (NASH). Therapeutic activators of the AMP-A
Autor:
Ravi G. Kurumbail, Eric Johnson, Nicole Caspers, Timothy A. Subashi, Michael L. Vazquez, Francis Rajamohan, Lise R. Hoth, Neelu Kaila, Kieran F. Geoghegan, Ciarán N. Cronin, Seungil Han
Publikováno v:
Acta Crystallographica Section F Structural Biology Communications. 72:840-845
Crystals of phosphorylated JAK1 kinase domain were initially generated in complex with nucleotide (ADP) and magnesium. The tightly bound Mg2+-ADP at the ATP-binding site proved recalcitrant to ligand displacement. Addition of a molar excess of EDTA h
Autor:
Alfin D. N. Vaz, T. Eric Ballard, Upendra P. Dahal, Andrew J. Bessire, Kieran F. Geoghegan, Richard P. Schneider
Publikováno v:
Rapid Communications in Mass Spectrometry. 29:2175-2183
Rationale The covalent modification of proteins by toxicants, new chemical entities or drug molecules, either by metabolic activation or the presence of inherently reactive functional groups, is commonly implicated in organ toxicity and idiosyncratic
Autor:
Shenping Liu, Lee R. Roberts, Erik C. Hett, Mihir D. Parikh, Ariamala Gopalsamy, Kieran F. Geoghegan, Ralph P. Robinson, Michael A. Tones, Lyn H. Jones, Robert E. Kyne, Hua Xu, Carol A. Menard, Arjun Narayanan
Publikováno v:
ACS Chemical Biology. 10:1094-1098
This work describes the first rational targeting of tyrosine residues in a protein binding site by small-molecule covalent probes. Specific tyrosine residues in the active site of the mRNA-decapping scavenger enzyme DcpS were modified using reactive
Autor:
Erik C. Hett, Parag Sahasrabudhe, Mathew T. Pletcher, R. Aldrin Denny, Alexandria P. Taylor, Shenping Liu, Arindrajit Basak, Andrew C. Flick, Paul D. Bonin, Eugene Lvovich Piatnitski Chekler, Ingrid A. Stock, Lyn H. Jones, Shores C. Salter, Kieran F. Geoghegan
Publikováno v:
MedChemComm. 6:1018-1023
Medicinal chemistry techniques, including structure-based molecular design, fragment replacement and synthetic library enablement, were used to create potent inhibitors of bromodomain and extraterminal domain (BET) and CREB bindingprotein bromodomain
Autor:
David W. Piotrowski, Jennifer A. Doudna, Kim F. McClure, Spiros Liras, Michael W. Bolt, Bruce A. Maguire, Austin Huang, Robert Dullea, Donna N. Petersen, Jun Xiao, Tim Rolph, Liuqing Wei, Jamie H. D. Cate, Allyn T. Londregan, Kieran F. Geoghegan, Nathanael G. Lintner, Paula M. Loria
Publikováno v:
PLoS biology, vol 15, iss 3
PLoS Biology
PLoS Biology, Vol 15, Iss 3, p e2001882 (2017)
PLoS Biology
PLoS Biology, Vol 15, Iss 3, p e2001882 (2017)
Proprotein convertase subtilisin/kexin type 9 (PCSK9) plays a key role in regulating the levels of plasma low-density lipoprotein cholesterol (LDL-C). Here, we demonstrate that the compound PF-06446846 inhibits translation of PCSK9 by inducing the ri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cce1f6bc26417b37506fac86c75c8950
https://escholarship.org/uc/item/3p3893k1
https://escholarship.org/uc/item/3p3893k1